CAREDX INC. - COMMON STOCK

CareDx Reports First Quarter 2022 Results

05 May 2022 16:01:02 By Nasdaq GlobeNewswire

CareDx Validates Clinical Performance of AlloMap Kidney to Comprehensively Assess Transplant Rejection

05 May 2022 07:00:03 By Nasdaq GlobeNewswire

CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement Award

28 Apr 2022 10:45:00 By Nasdaq GlobeNewswire

CareDx Extends Artificial Intelligence Leadership to Heart Transplantation

28 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

CareDx to Report First Quarter 2022 Financial Results

27 Apr 2022 16:01:00 By Nasdaq GlobeNewswire

International Society for Heart and Lung Transplantation Foundation Selects Reg Seeto as Corporate Chair

27 Apr 2022 09:15:00 By Nasdaq GlobeNewswire

CareDx Demonstrates Potential of AlloHeme and AlloCell for Allogeneic Cell Transplant and Therapy Monitoring at Transplantation & Cellular Therapy Meetings

22 Apr 2022 07:00:00 By Nasdaq GlobeNewswire

CareDx Supports UC Davis Health Pluralist Program Aimed at Reducing Health Disparities in Organ Transplantation

21 Apr 2022 07:10:00 By Nasdaq GlobeNewswire

CareDx Showcases Leadership with Over 25 Oral Presentations and Posters at the International Society for Heart and Lung Transplantation Meeting

20 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

CareDx Reports Over 200,000 Heart Transplant Patient Results Served

14 Apr 2022 07:41:49 By Nasdaq GlobeNewswire

CareDx, the Leading Sponsor of UNOS Transplant Management Forum, Demonstrates the Value of Digital Solutions to Improve Pre-Transplant Patient Referral and Waitlisting Workflow

11 Apr 2022 07:00:00 By Nasdaq GlobeNewswire

CareDx to Host Symposium at CEoT Featuring the Latest Multimodality Innovations in Kidney and Lung Transplant Surveillance

06 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

CareDx Partners with the European Society for Organ Transplantation to Provide Clinical Evidence Supporting the Use of AlloSeq cfDNA with European Transplant Healthcare Professionals

30 Mar 2022 07:00:00 By Nasdaq GlobeNewswire

CareDx Partners with HeartBrothers Foundation to Help Patients Living with Heart Failure and Heart Transplant

29 Mar 2022 07:00:00 By Nasdaq GlobeNewswire

CareDx’s AlloCare App Now Integrated with TxAccess to Help Pre-Transplant Patients Navigate the Waitlist Process

24 Mar 2022 07:00:00 By Nasdaq GlobeNewswire

CareDx Announces XenoSure and XenoMap

23 Mar 2022 07:00:00 By Nasdaq GlobeNewswire

UPDATE -- CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community

23 Mar 2022 06:00:00 By Nasdaq GlobeNewswire

CareDx Brings Together Leading Transplant Experts to Share Latest Advancements in the Field of Xenotransplantation

16 Mar 2022 07:00:00 By Nasdaq GlobeNewswire

CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community

14 Mar 2022 20:06:14 By Nasdaq GlobeNewswire

CareDx Announces Cibiltech Initiates CIBIL Study Using iBox Artificial Intelligence to Monitor Kidney Transplant Patients

03 Mar 2022 07:00:01 By Nasdaq GlobeNewswire